Sourcing in the pharmaceutical industry is global and digitized. The ease with which buyers can search the internet today for APIs, intermediates, excipients, specialty chemicals and other pharmaceutical raw materials and find hundreds of manufacturers, distributors, traders and chemical companies is a result of web technology.
However, the primary distinction between both models is that while one model tries to aid the user to find out companies, the other tries to make it easier for the purchasing needs of the pharmaceutical industry. B2B Pharmaceutical Marketplace aids purchasers to find appropriate suppliers, communicate their needs, send an RFQ, and investigate sourcing possibilities.
The primary goal of a general trade directory is to be a business discovery site. Basic information like name, address, contacts, products or services, business category, website or company description are generally included in a company's profile.
The main goal is very simple: to assist users in finding businesses.
A search for chemical manufacturers, for instance, can include a directory, company profiles and then one by one reaching out to companies. This can be beneficial in early research processes, but the bulk of the procurement process goes to the buyer.
The buyer is required to still:
A general directory may be helpful as a starting point but isn't necessarily intended to facilitate the entire pharmaceutical sourcing process.
A B2B pharma marketplace has a more targeted approach. Rather than being based on companies, it aims to be based on the buying and selling of the pharmaceutical and life sciences ecosystem.
Depending on platform, pharmaceutical products can be searched for by the buyer.
The main distinction is that the search is concerned with.
A general directory asks him:
“Which companies exist?”
A niche pharmaceutical market is more concerned with:
“Who are the suppliers that might be able to fulfill this particular sourcing need?”
This product and procurement driven approach helps a pharma marketplace be more relevant for the pharmaceutical buyers. Buyers should be aware however, that the mere fact of participation in a marketplace does not constitute approval, GMP compliance or suitability for a given pharmaceutical application. Buyer shall continue to be responsible for supplier qualification and due diligence.
When contrasting their main functions, their difference becomes more apparent.
|
Feature |
General Trade Directory |
B2B Pharma Marketplace |
|
Main purpose |
Business discovery |
Pharmaceutical sourcing |
|
Industry focus |
Usually broad |
Pharmaceutical/life sciences |
|
Product discovery |
General |
Pharma-specific |
|
Supplier discovery |
Company-focused |
Product and sourcing-focused |
|
RFQs |
May be limited |
Often central to sourcing |
|
Buyer audience |
Broad business audience |
Pharma procurement professionals |
|
Pharmaceutical terminology |
Limited |
Industry-specific |
|
Global sourcing |
Varies |
Typically a core use case |
|
Procurement workflow |
Limited |
More structured |
|
Supplier qualification |
Usually buyer-led |
Buyer-led, with platform-specific information/tools |
Both services aren't always the best. They address various issues. A trade directory can be useful if you want to find businesses while a specific market place can be more useful if you are looking to find a particular product that you need from a supplier that is relevant to your needs.
A pharmaceutical procurement process is no simple matter of locating a supplier that will offer the lowest price. Factors like quality, specifications, manufacturing location, documentation, traceability, regulatory requirements, and reliability of materials supply are important considerations, as materials can become part of regulated pharmaceutical products.
A buyer seeking to obtain an API, for instance, might require more than just a list of chemical companies. The buyer wants to know who provides the necessary API, get a good idea of the product's needs, and be able to send a well-defined request for a product to be sourced.
This is especially beneficial for supplier discovery, as it is specific to the industry.
Consider two searches:
"Pharmaceutical companies in India.”
and
“Suppliers of an API or/and pharmaceutical raw material.”
The first search yields a wide array of companies. The second represents an actual procurement requirement.
A specialty pharma marketplace can categorize products and suppliers by pharma type, providing buyers the opportunity to go from a general market opportunity to a more specific sourcing opportunity.
This can save companies a lot of time from looking at irrelevant companies for procurement teams. It can also facilitate buyers in their search of alternative suppliers if the present supplier is unable to fulfill the requirement.
A key difference between marketplace and traditional directory is its ability to help with requests for quotation (RFQs).
An RFQ enables the buyer to express their requirements in a structured way.
For example, an API sourcing request may include:
A marketplace that focuses on procurement can facilitate the initial sourcing dialogue, instead of sending the same requests to multiple companies.
But, an RFQ does not supersede the technical, regulatory or quality qualification. It just makes the business sourcing process more efficient.
A basic company profile could simply say that:
"We supply pharmaceutical chemicals."
This is helpful, but it might not be sufficient for the procurer.
It is advisable for the buyer to be aware of:
Knowing the real chain is especially critical in the case of pharmaceutical materials.
Commercial marketplace is not a regulatory prequalification system. But supplier and manufacturer data is still a key component of the procurement process.
The modern pharmaceutical supply chains can cross international borders. The API can be sourced from a country, the intermediate from another and other raw materials from different manufacturing centres in a pharmaceutical company.
This creates both opportunities and risks.
A broader supplier network can help buyers:
A niche marketplace can therefore serve to add value by making the discovery of the supplier easier.
There is no single platform that is automatically the best pharma marketplace for every buyer.
The right choice depends on what a procurement team actually needs.
Before choosing a platform, buyers should consider:
Does the platform cover the APIs, raw materials, intermediates, excipients, or other products you actually source?
Are the suppliers listed relevant for pharmaceutical procurement?
Do buyers have a search function by product or CAS number or other identifier?
Is it possible to express the sourcing requirements in a structured format?
Does the platform allow for useful information to be provided for initial supplier evaluation?
Does it have the ability to reach suppliers from around the globe and manufacturing regions?
Reduces manual research and communication?
Is it clearly stated what is being verified and what the buyer will need to verify themselves?
The last is particularly important. The presence in the marketplace is not an indication of regulatory clearance or supplier qualification.
Choosing a supplier on a marketplace is just the first step in procurement.
Depending on the product and market, buyers may need to evaluate:
Therefore:
Marketplace discovery is not the end of supplier qualification; it is the start.
It's possible for a specialized pharma marketplace to be advantageous for manufacturers, distributors, and other suppliers as well.
Suppliers can target buyers who are actively looking for pharmaceutical materials, rather than selling to an extensive business market.
Potential benefits include:
But a Market Place listing doesn't guarantee business. The quality and price are still important factors, and documentation, responsiveness, manufacturing capacity and fulfilling buyer needs are still crucial.
ChemDmart is built to be a pharmaceutical and chemical marketplace for B2B suppliers, where you can discover suppliers, manage your RFQs, understand the intelligence of procurement, find leads and source globally.
This is a niche market for pharmaceutical and chemical products, which pharmaceutical procurement teams can explore for sourcing opportunities, rather than relying solely on generic company directories.
A key benefit of searching for APIs, pharmaceutical raw materials, intermediates, or specialty chemicals for suppliers is that a specialized sourcing environment can be used to identify potential suppliers and begin the conversation on ordering.
ChemDmart makes supplier discovery and sourcing easy and efficient, while the procurement, quality, technical and regulatory teams continue to make the decision on supplier and product suitability.
In the end, the distinction between a trade directory and a pharmaceutical marketplace is all about the buying process.
A general directory will usually respond to the question of:
"Who is the seller of such product?"
The special pharmaceutical marketplace seeks to answer:
“Who might be able to provide me with the pharmaceutical product I require and how can I start the conversation about the product sourcing?”
This is important as the supply chains of pharmaceutical products continue to globalize. Due diligence is still necessary when performing digital sourcing. Rather, it can help speed up supplier search, initial communication and organization.
It is possible to think of a general trade directory and a pharma marketplace as being similar, but they are definitely distinct in terms of their uses.
The major function of the trade directory is to make businesses discoverable. A dedicated pharmaceutical marketplace is designed around pharmaceutical sourcing, product discovery, supplier discovery, RFQs and procurement opportunities, all in an industry-specific environment.
For buyers the benefit is more than just access to more suppliers. It is being able to go to more relevant suppliers and more efficient ways to look for suppliers.